Arcturus Therapeutics Holdings (ARCT) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Q3 2025 value amounting to -$0.49.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) fell 8846.15% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.46, marking a year-over-year decrease of 512.82%. This contributed to the annual value of -$3.0 for FY2024, which is 16854.77% down from last year.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) amounted to -$0.49 in Q3 2025, which was down 8846.15% from -$0.34 recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year EPS (Weighted Average and Diluted) high stood at $4.44 for Q4 2022, and its period low was -$2.07 during Q2 2021.
- In the last 5 years, Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) had a median value of -$0.73 in 2022 and averaged -$0.6.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 40204.08% in 2022, then tumbled by 15347.59% in 2024.
- Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) stood at -$1.47 in 2021, then soared by 402.04% to $4.44 in 2022, then tumbled by 109.88% to -$0.44 in 2023, then crashed by 153.35% to -$1.11 in 2024, then surged by 55.91% to -$0.49 in 2025.
- Its last three reported values are -$0.49 in Q3 2025, -$0.34 for Q2 2025, and -$0.52 during Q1 2025.